Jiangsu Hengrui Medicine Co., Ltd.;Shanghai Hengrui Pharmaceutical Co., Ltd.
发明人:
Chenmin TIAN,Hao LI,Xun LIU
申请号：
US16627075
公开号：
US20200223941A1
申请日:
2018.06.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided is a pharmaceutical composition comprising a PCSK9 antibody or an antigen-binding fragment thereof in a histidine buffer. In addition, the pharmaceutical composition may also comprise saccharides and nonionic surfactants.
